News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,242 Results
Type
Article (28273)
Company Profile (67)
Press Release (267902)
Multimedia
Podcasts (23)
Webinars (8)
Section
Business (77421)
Career Advice (873)
Deals (11050)
Drug Delivery (44)
Drug Development (46192)
Employer Resources (78)
FDA (6881)
Job Trends (6946)
News (141935)
Policy (14329)
Tag
Academia (2194)
Accelerated approval (2)
Adcomms (14)
Allergies (35)
Alliances (24293)
ALS (44)
Alzheimer's disease (833)
Antibody-drug conjugate (ADC) (56)
Approvals (6903)
Artificial intelligence (156)
Autoimmune disease (10)
Automation (10)
Bankruptcy (82)
Best Places to Work (6096)
BIOSECURE Act (16)
Biosimilars (35)
Biotechnology (51)
Bladder cancer (40)
Brain cancer (14)
Breast cancer (162)
Cancer (1260)
Cardiovascular disease (63)
Career advice (724)
Career pathing (11)
CAR-T (80)
Cell therapy (219)
Cervical cancer (16)
Clinical research (35564)
Collaboration (470)
Compensation (66)
Complete response letters (5)
COVID-19 (2499)
CRISPR (37)
C-suite (118)
Cystic fibrosis (63)
Data (1295)
Denatured (4)
Depression (11)
Diabetes (109)
Diagnostics (2719)
Digital health (6)
Diversity (3)
Diversity, equity & inclusion (20)
Drug discovery (66)
Drug pricing (44)
Drug shortages (6)
Duchenne muscular dystrophy (38)
Earnings (23175)
Editorial (19)
Employer branding (9)
Employer resources (69)
Events (39642)
Executive appointments (321)
FDA (7531)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (435)
Gene editing (76)
Generative AI (15)
Gene therapy (189)
GLP-1 (301)
Government (3062)
Grass and pollen (2)
Guidances (24)
Healthcare (8724)
Huntington's disease (8)
IgA nephropathy (11)
Immunology and inflammation (53)
Indications (15)
Infectious disease (2637)
Inflammatory bowel disease (89)
Inflation Reduction Act (5)
Influenza (53)
Intellectual property (39)
Interviews (116)
IPO (5306)
IRA (23)
Job creations (1159)
Job search strategy (642)
Kidney cancer (6)
Labor market (15)
Layoffs (170)
Leadership (6)
Legal (2167)
Liver cancer (32)
Lung cancer (175)
Lymphoma (72)
Machine learning (5)
Management (29)
Manufacturing (132)
MASH (21)
Medical device (4206)
Medtech (4206)
Mergers & acquisitions (5992)
Metabolic disorders (260)
Multiple sclerosis (52)
NASH (8)
Neurodegenerative disease (41)
Neuropsychiatric disorders (6)
Neuroscience (1089)
NextGen: Class of 2025 (2699)
Non-profit (2593)
Now hiring (11)
Obesity (125)
Opinion (109)
Ovarian cancer (49)
Pain (37)
Pancreatic cancer (40)
Parkinson's disease (72)
Partnered (9)
Patents (91)
Patient recruitment (59)
Peanut (20)
People (25607)
Pharmaceutical (18)
Pharmacy benefit managers (5)
Phase I (13357)
Phase II (15266)
Phase III (10534)
Pipeline (616)
Policy (97)
Postmarket research (1314)
Preclinical (6138)
Press Release (42)
Prostate cancer (54)
Psychedelics (22)
Radiopharmaceuticals (107)
Rare diseases (211)
Real estate (2147)
Recruiting (32)
Regulatory (10313)
Reports (18)
Research institute (2148)
Resumes & cover letters (165)
Rett syndrome (3)
RNA editing (3)
RSV (50)
Schizophrenia (20)
Series A (74)
Series B (43)
Service/supplier (1)
Sickle cell disease (41)
Special edition (1)
Spinal muscular atrophy (77)
Sponsored (14)
Startups (1855)
Stomach cancer (5)
Supply chain (31)
Tariffs (16)
The Weekly (18)
Vaccines (807)
Venture capitalists (17)
Weight loss (60)
Women's health (10)
Worklife (5)
Date
Today (73)
Last 7 days (403)
Last 30 days (1225)
Last 365 days (15285)
2025 (4767)
2024 (16543)
2023 (19033)
2022 (25506)
2021 (27477)
2020 (24790)
2019 (19907)
2018 (15153)
2017 (14214)
2016 (13874)
2015 (16237)
2014 (12125)
2013 (10161)
2012 (10566)
2011 (11082)
2010 (9716)
Location
Africa (442)
Alabama (37)
Alaska (5)
Arizona (80)
Arkansas (6)
Asia (19252)
Australia (3851)
California (2572)
Canada (823)
China (247)
Colorado (105)
Connecticut (124)
Delaware (81)
Europe (41855)
Florida (443)
Georgia (90)
Hawaii (1)
Idaho (19)
Illinois (214)
India (15)
Indiana (118)
Iowa (3)
Japan (88)
Kansas (33)
Kentucky (15)
Louisiana (5)
Maine (11)
Maryland (557)
Massachusetts (2023)
Michigan (71)
Minnesota (129)
Missouri (38)
Montana (15)
Nebraska (12)
Nevada (14)
New Hampshire (19)
New Jersey (958)
New Mexico (12)
New York (858)
North Carolina (426)
North Dakota (8)
Northern California (1133)
Ohio (88)
Oklahoma (9)
Oregon (11)
Pennsylvania (601)
Puerto Rico (4)
Rhode Island (17)
South America (486)
South Carolina (7)
Southern California (968)
Tennessee (34)
Texas (416)
United States (10429)
Utah (65)
Virginia (66)
Washington D.C. (41)
Washington State (301)
West Virginia (2)
Wisconsin (20)
296,242 Results for "duke human vaccine institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and less affordable,” according to vaccine expert Paul Offit. It could also further complicate the picture for companies like Novavax.
May 1, 2025
·
3 min read
·
Heather McKenzie
Editorial
RFK Jr. Is Driving a Wedge Into Already Polarized Vaccine Conversations
When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and Human Services secretary are bringing down the hammer. What happens when there is no middle ground?
May 1, 2025
·
7 min read
·
Jef Akst
Vaccines
FDA Issues Back-to-Back Vaccine Approvals as RFK Jr. Takes HHS Seat
The approvals come as Robert F. Kennedy Jr.—who has been critical of vaccines—takes leadership of the Department of Health and Human Services.
February 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Thermo Fisher Scientific and Chan Zuckerberg Institute for Advanced Biological Imaging Collaborate to Further Understanding of Human Cells
March 28, 2025
·
4 min read
Vaccines
CDC Vaccine Advisory Board Meeting Postponed Days After RFK Jr. Confirmation
The postponed ACIP meeting comes barely a week after Robert F. Kennedy, Jr. was confirmed as Secretary of Health and Human Services, despite controversy regarding his anti-vaccine history.
February 21, 2025
·
2 min read
·
Tristan Manalac
Editorial
Kennedy’s Hunt for a Connection Between Vaccines and Autism Is a Sham
The Health and Human Services Secretary said that he will find and eliminate the cause of autism by September, an idea that suggests how little he knows about the condition.
April 17, 2025
·
3 min read
·
Dan Samorodnitsky
Drug Development
Saghmos Therapeutics Announces Collaboration with Duke Clinical Research Institute to Optimize Phase 3 Cardio-Renal Metabolic Study
Saghmos Therapeutics, Inc. (Saghmos), a privately held biopharmaceutical company, announced it will partner with the Duke Clinical Research Institute (DCRI) to optimize all aspects of and plan the operationalization of Saghmos’ Phase 3 study for its cardio-renal metabolic modulator ST-62516.
April 17, 2024
·
4 min read
Press Releases
Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
April 30, 2025
·
5 min read
Government
Kennedy Changes Tune on MMR Vaccine as Second Child Dies of Measles
Kennedy, a long-time opponent of vaccines, stated that the MMR vaccine is “the most effective way” to combat the measles outbreak, which has already claimed the lives of two children in the U.S.
April 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Replicate Bioscience Announces Publication of First-in-Human Data for Its Optimized srRNA Rabies Vaccine in Nature Communications
February 7, 2025
·
5 min read
1 of 29,625
Next
